Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Share News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 502.00
Bid: 490.00
Ask: 502.00
Change: 12.00 (2.45%)
Spread: 12.00 (2.449%)
Open: 490.00
High: 502.00
Low: 490.00
Prev. Close: 490.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Gooch & Housego stays on track with record order book

Thu, 04th Oct 2018 08:19

(Sharecast News) - Optical systems and components manufacturer Gooch & Housego on Thursday reported a record order book after benefiting from "positive market conditions" in the industrial sector.The company said its order book stood at £96.1m at the end of the 12 months leading to 30 September, up 33% compared to the same point last year, with components used in microelectronic manufacturing and high reliability fibre couplers for undersea cables proving particularly vital.As such, the company said its final results for the year will be in line with prior expectations.Mark Webster, chief executive of Gooch & Housego, said: "We have been able to take advantage of positive market conditions and execute on our long-term strategy. Our strong performance has enabled us to continue to invest in manufacturing capacity and R&D and to bring complementary new technologies and customers into G&H through acquisitions."The AIM traded outfit also reported that it was currently "pleased" with the output and contribution of newly acquired VITL and Gould Fiber Optics, which it added to the business in August and September respectively.VITL manufactures medical devices while Gould is a supplier of key enabling components to tier 1 US aerospace and defence customers.Gooch also shut down the operations of its light measurement business in Orlando, Florida, as the non-core business had a history of delivering marginal returns and made a small loss in 2018."While we remain aware of potential macroeconomic and political risks, our robust order book combined with greater diversification means the board remains confident that the group is well positioned for further growth," said Webster.Gooch & Housego's shares were down 0.4% at 1,850.00p at 0847 BST.
More News
9 Jun 2015 08:00

Gooch & Housego Interim Profit Boosted By Industrial Revenue Growth

Read more
9 Jun 2015 07:52

Tuesday broker round-up

Reed Elsevier: Barclays ups target price to 1,225p and lifts recommendation to overweight from equal-weight. HSBC Holdings: Investec reiterates hold and 620p target. Bernstein keeps target price at 650p. Goldman Sachs places estimates under review. Credit Suisse reiterates underperform and 580p targ

Read more
9 Jun 2015 05:28

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Jun 2015 16:00

LONDON MARKET CLOSE: FTSE 100 Ends Down; Takeover Rumours Drive Stocks

Read more
8 Jun 2015 14:56

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Jun 2015 05:33

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Jun 2015 15:03

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Jun 2015 05:21

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jun 2015 15:22

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jun 2015 05:11

Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Jun 2015 15:03

Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Jun 2015 05:14

Earnings, Trading Statements Calendar - Week Ahead

Read more
2 Jun 2015 15:25

Earnings, Trading Statements Calendar - Week Ahead

Read more
2 Jun 2015 14:55

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Apr 2015 16:42

Wednesday broker round-up:

AstraZeneca: Morgan Stanley lifts target price to 4,500p from 4,300p, reiterates underweight. BG Group: Canaccord Genuity improves target price to 1,300p from 1,016p and downgrades to hold. GlaxoSmithKline: Deutsche Bank raises target price to 1,600p from 1,300p and reiterates hold. Tate&Lyle: Num

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.